Phospho-CrkL (Tyr207) (G4) rabbit mAb

Catalog #: 2091
Select Your Size Price
200 uL (0.5 mg/mL)(2091-200) $570.00
20 uL (0.5 mg/mL)(2091-20) $210.00
From $210.00

Need to make a custom order?

Contact us

Note

20 μL is enough antibody for at least 20 Western blots.

Product Overview

Description
CrkL (v-Crk sarcoma virus CT10 oncogene-like protein) is an adaptor protein composed of one Src Homology 2 (SH2) and two Src Homology 3 (SH3) domains separated by flexible linker sequences that act as building blocks to assemble multiprotein complexes (1). The Crk adaptor proteins (Crk and CrkL) constitute an integral part of a network of essential signal transduction pathways in humans and other organisms that act as major convergence points in tyrosine kinase signaling. CRKL is required for the normal development of multiple tissues that rely on fibroblast growth factor 8 (FGF8). Phosphorylation of Crk on Tyr 221 or CrkL on Tyr 207 causes intramolecular binding of the linker region to the SH2 domain, sequestering the SH2 and SH3N and preventing them from binding target proteins (2,3). Mounting evidence indicates that dysregulation of Crk proteins is associated with human diseases, including cancer and susceptibility to pathogen infections.

Product Details

Product Details
Specification Description
Applications Flow Cytometry, WB
Clone CrkLY207-G4
Format Unconjugated
Validated Reactivity Human, Mouse
Cross Reactivity Predicted to work with mouse, rat, and other homologues.
Detection Anti-Rabbit IgG
Clonality Monoclonal
Immunogen A synthetic phospho-peptide corresponding to residues surrounding Tyr207 of human phospho CrkL
Formulation 1X PBS, 0.02% NaN3, 50% Glycerol, 0.1% BSA
Isotype Rabbit IgGk
Preparation Protein A+G
Recommended Usage 1µg/mL – 0.001µg/mL. It is recommended that the reagent be titrated for optimal performance for each application. See product image legends for additional information.
Storage -20ºC
Pseudonyms Crk-like protein; CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like
Uniprot ID P46109
References 1. Tten Hoeve, J.,et al., (1993). Oncogene 8: 2469-2474.
2. Rosen MK, et al., (1995) Nature, 374 477-479.
3. Kobashigawa Y, et al., (2007) Nat Struct Mol Biol.14:503-510.

Images

Cell Culture Products
Flow cytometric analysis of K562 cells treated with imatinib (red) or treated with pervanadate (green) using Phospho-CRKL (Tyr207) (G4) Rabbit mAb CRKLY207-G4 #2091 at 0.05 ug/mL, or concentration-matched Rabbit (G9) mAb IgG Isotype Control #2141 for cells treated with imatinib (black) or treated with pervanadate (blue).
Cell Culture Products
Western blot analysis of K562 cell extract untreated or treated with imatinib using 1ng/mL CrkL (Tyr207) antibody CrkLY207-G4. Cat. #2091.
Cell Culture Products
Peptide blocking flow cytometric analysis of K562 cells secondary antibody only negative control (light blue) or treated with imatinib (red) or treated with pervanadate (green) or imatinib and blocked with phospho-peptide (black) or pervanadate and blocked with phospho peptide (gold) or imatinib and blocked with non-phospho peptide (dark blue) or pervanadate and blocked with non-phospho peptide (purple) using Phospho-CrkL (Tyr207) antibody CrkLY207-G4 at 0.01µg/mL. Cat. #2091.
Cell Culture Products
Western blot analysis of NIH3T3 cell extract using 1µg/mL Phospho-CrkL (Tyr207) antibody CrkLY207-G4. Cat. #2091.
Cell Culture Products
Western blot of E10.5 mouse wild-type (+/+) or Crkl knock out (-/-) whole embryos. The red channel was stained using a β-actin loading control and the green channel was stained using 1:500 dilution of Phospho-CrkL (Tyr207) antibody CrkLY207-G4 Cat. #2091. Phospho CrkL antibody staining is absent in the knock out lysate.
Cell Culture Products
Flow cytometric analysis of K562 cells secondary antibody only negative control (blue) or treated with imatinib (red) or with pervanadate (green) using 0.05 µg/mL of Phospho-CrkL (Tyr207) antibody CrkLY207-G4 (Abwiz Cat. #2091) or Company C antibody at 0.1ug/mL.

Associated Products